Literature DB >> 3703257

Survival of children with brain tumors: SEER Program, 1973-1980.

P K Duffner, M E Cohen, M H Myers, H W Heise.   

Abstract

Eight hundred eighty-seven children with brain tumors were identified by the SEER registries (1973-1980). Twenty-five percent were low-grade supratentorial astrocytomas, medulloblastomas were 23%, cerebellar astrocytomas 12%, high-grade supratentorial astrocytomas 11%, brainstem gliomas 9%, and ependymomas 8%. The worst survivals were in children less than 2 years of age, and the best were in those aged 10 to 14 years. Five-year survivals of children with cerebellar astrocytomas were 91%, low-grade supratentorial astrocytomas 71%, high-grade supratentorial astrocytomas 35%, medulloblastomas 39%, ependymomas 28%, and brainstem gliomas 18%.

Entities:  

Mesh:

Year:  1986        PMID: 3703257     DOI: 10.1212/wnl.36.5.597

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  32 in total

1.  Pediatric supratentorial high-grade glioma: multicenter retrospective observational study of the Korean Society for Pediatric Neuro-Oncology.

Authors:  Tae-Young Jung; Ji Yeoun Lee; Dong-Seok Kim; Hyeon Jin Park; Chae-Yong Kim; Young-Shin Ra; Mee-Jeong Lee; Seong-Ho Kim; Hee-Jo Baek; Il Han Kim; Kyung Duk Park; Seung-Ki Kim
Journal:  J Neurooncol       Date:  2014-11-04       Impact factor: 4.130

2.  Long-term survival in children under 3 years of age with low-grade astrocytoma.

Authors:  Roberto Rivera-Luna; Marta Zapata-Tarrés; Aurora Medina-Sansón; Enrique López-Aguilar; Ana Niembro-Zúñiga; J Amador Zarco; Alfonso Marhx-Bracho; Fernando Rueda-Franco; Leticia Bornstein-Quevedo
Journal:  Childs Nerv Syst       Date:  2007-01-17       Impact factor: 1.475

3.  Efficacy of high-dose chemotherapy or standard salvage therapy in patients with recurrent medulloblastoma.

Authors:  Sridharan Gururangan; Jeanne Krauser; Melody A Watral; Tim Driscoll; Nicole Larrier; David A Reardon; Jeremy N Rich; Jennifer A Quinn; James J Vredenburgh; Annick Desjardins; Roger E McLendon; Herbert Fuchs; Joanne Kurtzberg; Henry S Friedman
Journal:  Neuro Oncol       Date:  2008-08-28       Impact factor: 12.300

4.  Phase II trial of temozolomide in children with recurrent high-grade glioma.

Authors:  A Ruggiero; G Cefalo; M L Garré; M Massimino; C Colosimo; G Attinà; I Lazzareschi; P Maurizi; V Ridola; G Mazzarella; M Caldarelli; C Di Rocco; E Madon; M E Abate; A Clerico; A Sandri; R Riccardi
Journal:  J Neurooncol       Date:  2006-03       Impact factor: 4.130

5.  Brain tumors with symptomatic onset in the first two years of life.

Authors:  M R Balestrini; R Micheli; L Giordano; G Lasio; S Giombini
Journal:  Childs Nerv Syst       Date:  1994-03       Impact factor: 1.475

6.  Subgroup-specific outcomes of children with malignant childhood brain tumors treated with an irradiation-sparing protocol.

Authors:  Eveline Teresa Hidalgo; Matija Snuderl; Cordelia Orillac; Svetlana Kvint; Jonathan Serrano; Peter Wu; Matthias A Karajannis; Sharon L Gardner
Journal:  Childs Nerv Syst       Date:  2019-08-02       Impact factor: 1.475

7.  Postoperative chemotherapy without radiation in young children with malignant non-astrocytic brain tumours. A report from the Australia and New Zealand Childhood Cancer Study Group (ANZCCSG).

Authors:  L White; H Johnston; R Jones; H Mameghan; V Nayanar; W McWhirter; S Kellie; K Waters; I Toogood
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

8.  Malignant hemispheric tumors in childhood.

Authors:  E Hoppe-Hirsch; J F Hirsch; A Lellouch-Tubiana; A Pierre-Kahn; C Sainte-Rose; D Renier
Journal:  Childs Nerv Syst       Date:  1993-06       Impact factor: 1.475

9.  Preirradiation chemotherapy for very young children with brain tumors.

Authors:  M J Jeng; T K Chang; T T Wong; Y L Hsien; R B Tang; B Hwang
Journal:  Childs Nerv Syst       Date:  1993-06       Impact factor: 1.475

10.  Pediatric brain tumors in Nigeria: clinical profile, management strategies, and outcome.

Authors:  E O Uche; M T Shokunbi; A O Malomo; E E U Akang; I Lagunju; S D Amanor-Boadu
Journal:  Childs Nerv Syst       Date:  2013-04-18       Impact factor: 1.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.